DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fosamax (Alendronate) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Fosamax (Alendronate). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (1372)
     Osteonecrosis (497)Anxiety (257)Death (253)more >>

Cases resulting in a serious event (1344)
     Osteonecrosis (493)Anxiety (256)Death (253)more >>

Cases resulting in death (287)
     Osteonecrosis (23)Osteomyelitis (11)Anxiety (8)more >>

Cases resulting in life threatening events (57)
     Osteomyelitis (5)Agranulocytosis (5)Sepsis (5)more >>

Cases resulting in hospitalization (687)
     Osteonecrosis (343)Osteomyelitis (193)Anxiety (181)more >>

Cases resulting in disability (276)
     Osteonecrosis (184)Anxiety (116)Osteomyelitis (86)more >>

Cases resulting in other serious reactions (654)
     Osteonecrosis (391)Anxiety (204)Osteomyelitis (187)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Fosamax (Alendronate). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 45 year old female receiving Fosamax (Alendronate)

Reported by a physician from Japan on 2007-10-31

Patient: 45 year old female

Adverse reactions / side effects: Liver Disorder

Suspect drug(s):
Celecoxib
    Administration route: Oral

Fosamax
    Administration route: Oral
    Indication: Osteoporosis



Adverse event in 60 year old female receiving Fosamax (Alendronate)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-31

Patient: 60 year old female, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Dental Alveolar Anomaly, Fibrous Dysplasia of Bone, Osteomyelitis Chronic

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Amlodipine; Diovan; Pravastatin; Pravastatin Sodium



Adverse event in female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-31

Patient: female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in 75 year old female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Japan on 2007-10-31

Patient: 75 year old female

Adverse reactions / side effects: Liver Function Test Abnormal

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in 48 year old female receiving Fosamax (Alendronate)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Migraine, Tooth Loss, Weight Decreased, Dermatitis Atopic, Oral Infection, Gingival Disorder, Temporomandibular Joint Syndrome, Hypoaesthesia Oral, Impaired Healing, Uterine Disorder, Carpal Tunnel Syndrome, Menopausal Disorder, Pain in JAW

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax
    Administration route: Oral
    Indication: Osteopenia

Fosamax
    Administration route: Oral
    Start date: 1998-12-15
    End date: 2002-10-29

Fosamax
    Start date: 2002-10-30

Fosamax
    Administration route: Oral
    End date: 2006-01-01

Fosamax
    Administration route: Oral
    Indication: Osteoporosis

Fosamax
    Administration route: Oral
    Start date: 1998-12-15
    End date: 2002-10-29

Fosamax
    Start date: 2002-10-30

Fosamax
    Administration route: Oral
    End date: 2006-01-01

Other drugs received by patient: Prempro; Premarin; Enbrel; Methotrexate; Study Drug (Unspecified); Vitamin E; Ascorbic Acid; Vitamins (Unspecified); Calcium (Unspecified); Arava; Iron (Unspecified)



Adverse event in female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-31

Patient: female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-31

Patient: female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in 61 year old female receiving Fosamax (Alendronate)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31

Patient: 61 year old female, weighing 61.0 kg (134.2 pounds)

Adverse reactions / side effects: Wrist Fracture, Upper Limb Fracture, Osteomyelitis, Chronic Obstructive Pulmonary Disease, Anxiety, Carotid Artery Stenosis, HIP Fracture, Renal Failure, Osteonecrosis, Alcoholism, Diarrhoea, Upper Gastrointestinal Haemorrhage, Depression, Bronchitis, Tendonitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Actonel
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-01-24
    End date: 2005-05-01

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2003-01-27
    End date: 2005-01-24

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2003-01-27
    End date: 2005-01-24



Adverse event in female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-31

Patient: female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in 81 year old male receiving Fosamax (Alendronate)

Reported by a physician from France on 2007-10-30

Patient: 81 year old male

Adverse reactions / side effects: Skin Cancer

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Hydrocortisone; Fluindione; Lactulose; Spironolactone; Levothyroxine Sodium



Adverse event in 57 year old male receiving Fosamax (Alendronate)

Reported by a lawyer from United States on 2007-10-30

Patient: 57 year old male

Adverse reactions / side effects: Tooth Loss, Gingival Bleeding, Dental Caries, Deafness, Atrial Fibrillation, Temporomandibular Joint Syndrome, Oral Pain, Dehydration, Pancreatitis, Pain in JAW

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Prilosec



Adverse event in 78 year old female receiving Fosamax (Alendronate)

Reported by a physician from Japan on 2007-10-30

Patient: 78 year old female

Adverse reactions / side effects: White Blood Cell Count Decreased, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Pentcillin; [therapy Unspecified]



Adverse event in 28 year old male receiving Fosamax (Alendronate)

Reported by a physician from United States on 2007-10-30

Patient: 28 year old male, weighing 90.0 kg (198.0 pounds)

Adverse reactions / side effects: Myasthenia Gravis, Urinary Tract Infection, Pseudomonas Infection, Petechiae, Osteomyelitis, Herpes Zoster, Anxiety, Skin Laceration, Osteonecrosis, Respiratory Failure, Bronchiectasis, Abscess

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Mestinon; Prednisone



Adverse event in 87 year old female receiving Fosamax (Alendronate)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30

Patient: 87 year old female, weighing 50.0 kg (110.0 pounds)

Adverse reactions / side effects: Anxiety, Osteonecrosis, Fear, Osteomyelitis, Blindness, Macular Degeneration

Suspect drug(s):
Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1996-02-13

Fosamax
    Administration route: Oral
    Start date: 2005-01-06
    End date: 2006-03-25

Other drugs received by patient: Coumadin; Cephalexin; Atenolol; Hydrocodone Bitartrate



Adverse event in 75 year old female receiving Fosamax (Alendronate)

Reported by a physician from United States on 2007-10-30

Patient: 75 year old female

Adverse reactions / side effects: DRY Eye

Adverse event resulted in: disablity

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in female receiving Fosamax (Alendronate)

Reported by a physician from Japan on 2007-10-30

Patient: female, weighing 44.0 kg (96.8 pounds)

Adverse reactions / side effects: Agranulocytosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Celecoxib
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2007-08-07
    End date: 2007-09-25

Enbrel
    Indication: Rheumatoid Arthritis
    Start date: 2007-08-13
    End date: 2007-09-24

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2007-02-20
    End date: 2007-09-28

Iscotin
    Administration route: Oral
    Indication: Antibiotic Prophylaxis
    Start date: 2007-08-16
    End date: 2007-09-25

Other drugs received by patient: Predonine; Famotidine; Magnesium Oxide; Sucralfate; Lendormin; Norvasc; BUP-4



Adverse event in receiving Fosamax (Alendronate)

Reported by a physician from Japan on 2007-10-30

Patient:

Adverse reactions / side effects: Liver Disorder

Suspect drug(s):
Celecoxib
    Administration route: Oral

Fosamax
    Administration route: Oral
    Indication: Osteoporosis



Adverse event in 72 year old female receiving Fosamax (Alendronate)

Reported by a physician from Japan on 2007-10-30

Patient: 72 year old female, weighing 44.0 kg (96.8 pounds)

Adverse reactions / side effects: Agranulocytosis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Celecox
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2007-08-07
    End date: 2007-09-25

Enbrel
    Indication: Rheumatoid Arthritis
    Start date: 2007-08-13
    End date: 2007-09-24

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2007-02-20
    End date: 2007-09-28

Iscotin
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2007-08-16
    End date: 2007-09-25

Other drugs received by patient: Predonine; Famotidine; Sucralfate; Norvasc



Adverse event in 61 year old male receiving Fosamax (Alendronate)

Reported by a physician from United States on 2007-10-30

Patient: 61 year old male, weighing 89.0 kg (195.8 pounds)

Adverse reactions / side effects: Weight Decreased, Tinnitus, Contusion, Osteomyelitis, Oral Herpes, Herpes Zoster, Skin Ulcer, Behcet's Syndrome, Oedema Peripheral, Pneumothorax, Eye Disorder, Transient Ischaemic Attack, Myositis, Aphthous Stomatitis, Gouty Arthritis, Pneumonia, Osteonecrosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Celebrex; Lisinopril; Valtrex; Prednisone



Adverse event in 60 year old female receiving Fosamax (Alendronate)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-30

Patient: 60 year old female, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Dental Alveolar Anomaly, Fibrous Dysplasia of Bone, Osteomyelitis Chronic

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax (Alendronate)

Other drugs received by patient: Amlodipine; Diovan; Pravastatin; Pravastatin Sodium



Adverse event in male receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-30

Patient: male

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in 47 year old female receiving Fosamax (Alendronate)

Reported by a physician from United States on 2007-10-30

Patient: 47 year old female

Adverse reactions / side effects: Tooth Loss, Pain, Periodontal Disease, Osteomyelitis, Failure of Implant, Joint Range of Motion Decreased, Uterine Leiomyoma, Depression, Bone Disorder, Exostosis, Trismus, Gingival Bleeding, Fistula, Dental Caries, Hypoaesthesia, Anxiety, Osteonecrosis, Impaired Healing, Neoplasm Malignant, Swelling, Uterine Disorder, Abscess, Gingival Infection, Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Fosamax
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2003-06-01
    End date: 2003-12-01

Fosamax
    Administration route: Oral
    Start date: 2003-12-01
    End date: 2005-03-01

Fosamax
    Administration route: Oral
    Start date: 2005-03-01
    End date: 2006-01-01



Adverse event in female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-30

Patient: female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-30

Patient: female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)



Adverse event in 71 year old female receiving Fosamax (Alendronate)

Reported by a consumer/non-health professional from Australia on 2007-10-29

Patient: 71 year old female

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Fosamax (Alendronate)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009